1. Home
  2. LTRN vs ORIS Comparison

LTRN vs ORIS Comparison

Compare LTRN & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • ORIS
  • Stock Information
  • Founded
  • LTRN 2013
  • ORIS 2014
  • Country
  • LTRN United States
  • ORIS China
  • Employees
  • LTRN N/A
  • ORIS N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • ORIS Farming/Seeds/Milling
  • Sector
  • LTRN Health Care
  • ORIS Consumer Staples
  • Exchange
  • LTRN Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • LTRN 36.0M
  • ORIS 19.5M
  • IPO Year
  • LTRN 2020
  • ORIS 2024
  • Fundamental
  • Price
  • LTRN $3.16
  • ORIS $0.53
  • Analyst Decision
  • LTRN Strong Buy
  • ORIS
  • Analyst Count
  • LTRN 1
  • ORIS 0
  • Target Price
  • LTRN $25.00
  • ORIS N/A
  • AVG Volume (30 Days)
  • LTRN 50.9K
  • ORIS 151.3K
  • Earning Date
  • LTRN 08-07-2025
  • ORIS 02-21-2025
  • Dividend Yield
  • LTRN N/A
  • ORIS N/A
  • EPS Growth
  • LTRN N/A
  • ORIS N/A
  • EPS
  • LTRN N/A
  • ORIS 0.17
  • Revenue
  • LTRN N/A
  • ORIS $15,014,000.00
  • Revenue This Year
  • LTRN N/A
  • ORIS N/A
  • Revenue Next Year
  • LTRN N/A
  • ORIS N/A
  • P/E Ratio
  • LTRN N/A
  • ORIS $3.19
  • Revenue Growth
  • LTRN N/A
  • ORIS N/A
  • 52 Week Low
  • LTRN $2.55
  • ORIS $0.50
  • 52 Week High
  • LTRN $6.12
  • ORIS $56.01
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 46.11
  • ORIS N/A
  • Support Level
  • LTRN $3.05
  • ORIS N/A
  • Resistance Level
  • LTRN $3.33
  • ORIS N/A
  • Average True Range (ATR)
  • LTRN 0.18
  • ORIS 0.00
  • MACD
  • LTRN 0.01
  • ORIS 0.00
  • Stochastic Oscillator
  • LTRN 26.19
  • ORIS 0.00

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: